Your browser doesn't support javascript.
loading
Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort.
Sugrue, Jamie A; Posseme, Céline; Tan, Ziyang; Pou, Christian; Charbit, Bruno; Bondet, Vincent; Bourke, Nollaig M; Brodin, Petter; Duffy, Darragh; O'Farrelly, Cliona.
Afiliación
  • Sugrue JA; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Posseme C; Translational Immunology Unit, Institut Pasteur, Paris, France.
  • Tan Z; Science for Life Laboratory, Department of Women's and Children Health, Karolinska Institutet, 17165 Stockholm, Sweden.
  • Pou C; Science for Life Laboratory, Department of Women's and Children Health, Karolinska Institutet, 17165 Stockholm, Sweden.
  • Charbit B; Cytometry and Biomarkers UTechS, CRT, Institut Pasteur, Paris, France.
  • Bondet V; Translational Immunology Unit, Institut Pasteur, Paris, France.
  • Bourke NM; Discipline of Medical Gerontology, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
  • Brodin P; Science for Life Laboratory, Department of Women's and Children Health, Karolinska Institutet, 17165 Stockholm, Sweden.
  • Duffy D; Translational Immunology Unit, Institut Pasteur, Paris, France; Cytometry and Biomarkers UTechS, CRT, Institut Pasteur, Paris, France.
  • O'Farrelly C; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; School of Medicine, Trinity College Dublin, Dublin, Ireland. Electronic address: ofarrecl@tcd.ie.
Cell Rep Med ; 3(11): 100804, 2022 11 15.
Article en En | MEDLINE | ID: mdl-36334594
ABSTRACT
Natural resistance to infection is an overlooked outcome after hepatitis C virus (HCV) exposure. Between 1977 and 1979, 1,200 Rhesus D-negative Irish women were exposed to HCV-contaminated anti-D immunoglobulin. Here, we investigate why some individuals appear to resist infection despite exposure (exposed seronegative [ESN]). We screen HCV-resistant and -susceptible donors for anti-HCV adaptive immune responses using ELISpots and VirScan to profile antibodies against all know human viruses. We perform standardized ex vivo whole blood stimulation (TruCulture) assays with antiviral ligands and assess antiviral responses using NanoString transcriptomics and Luminex proteomics. We describe an enhanced TLR3-type I interferon response in ESNs compared with seropositive women. We also identify increased inflammatory cytokine production in response to polyIC in ESNs compared with seropositive women. These enhanced responses may have contributed to innate immune protection against HCV infection in our cohort.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis C / Hepacivirus Límite: Female / Humans Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis C / Hepacivirus Límite: Female / Humans Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article País de afiliación: Irlanda